Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma
Purpose: Chemoradiotherapy (CRT) is the current standard of care for patients diagnosed
with locally advanced anal squamous cell carcinoma (ASCC), but some patients develop …
with locally advanced anal squamous cell carcinoma (ASCC), but some patients develop …
[HTML][HTML] Perspective: do fasting, caloric restriction, and diets increase sensitivity to radiotherapy? A literature review
P Icard, L Ollivier, P Forgez, J Otz, M Alifano… - Advances in …, 2020 - Elsevier
Caloric starvation, as well as various diets, has been proposed to increase the oxidative
DNA damage induced by radiotherapy (RT). However, some diets could have dual effects …
DNA damage induced by radiotherapy (RT). However, some diets could have dual effects …
[HTML][HTML] Efficacy of large use of combined hypofractionated radiotherapy in a cohort of anti-PD-1 monotherapy-treated melanoma patients
P Saiag, R Molinier, A Roger, B Boru, Y Otmezguine… - Cancers, 2022 - mdpi.com
Simple Summary Melanoma patients who failed anti-PD-1 therapy have limited therapeutic
options. Some studies suggested the efficacy of radiotherapy combined with anti-PD-1 …
options. Some studies suggested the efficacy of radiotherapy combined with anti-PD-1 …
[HTML][HTML] Efficacy and safety of combined brain stereotactic radiotherapy and immune checkpoint inhibitors in non-small-cell lung cancer with brain metastases
J Porte, C Saint-Martin, T Frederic-Moreau… - Biomedicines, 2022 - mdpi.com
Background: To analyze the outcomes of patients with brain metastases (BM) from non-
small cell lung cancer (NSCLC) treated with immunotherapy (IT) and stereotactic …
small cell lung cancer (NSCLC) treated with immunotherapy (IT) and stereotactic …
Radiotherapy mucositis in head and neck cancer: prevention by low-energy surface laser
V Bourbonne, J Otz, RJ Bensadoun… - BMJ supportive & …, 2022 - spcare.bmj.com
Background Modern radiotherapy (RT) planning techniques and the use of oral supportive
care have reduced the occurrence of acute radiation-induced toxicities. Oral mucositis …
care have reduced the occurrence of acute radiation-induced toxicities. Oral mucositis …
Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar …
A Beddok, ML Chabi-Charvillat, T Kennel, J de Wolf… - Clinical Lung Cancer, 2023 - Elsevier
Introduction The objective of this study was to determine whether computed tomography
(CT) could be a useful tool for nonsolid lung nodule (NSN) treatment planning, surgery or …
(CT) could be a useful tool for nonsolid lung nodule (NSN) treatment planning, surgery or …
Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal canal carcinoma.
3565 Background: Chemoradiotherapy (CRT) is the current standard of care for patients
diagnosed with locally advanced anal squamous cell carcinoma (ASCC), but some patients …
diagnosed with locally advanced anal squamous cell carcinoma (ASCC), but some patients …
Tolerance of concurrent CDK inhibitor and radiation therapy in metastatic breast cancer patients.
e12598 Background: Palbociclib, a small-molecule inhibitor of cyclin-dependent kinases
(CDK4 and CDK6), combined with letrozole increases progression-free survival among …
(CDK4 and CDK6), combined with letrozole increases progression-free survival among …
Efficacité de la radiothérapie (RT) hypofractionnée au cours du mélanome avancé traité par monothérapie anti-PD-1
P Saiag, R Molinier, A Roger, B Boru… - … de Dermatologie et de …, 2021 - Elsevier
Introduction Effectuée à des doses suffisantes après le début des anti-PD-1, la RT peut
augmenter le taux de réponse complète (RC) et la survie sans progression (PFS). Notre …
augmenter le taux de réponse complète (RC) et la survie sans progression (PFS). Notre …
Abstract P4-12-05: A retrospective study of 27 patients with ER-positive, HER2 negative metastatic breast cancer treated with concomitant palbociclib and radiation …
A Beddok, A Arsene-Henry, B Porte, K Cao, L Bazire… - Cancer Research, 2020 - AACR
Background: Palbociclib, a small-molecule inhibitor of cyclin-dependent kinases (CDK4 and
CDK6), combined with letrozole increases progression-free survival among patients with …
CDK6), combined with letrozole increases progression-free survival among patients with …